Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP260730.RAXf4ymwU1EjdTgAC5ENfyIkAjISGmhO2Cg2rf1hCRAyQ130_assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260730.RAXf4ymwU1EjdTgAC5ENfyIkAjISGmhO2Cg2rf1hCRAyQ130_provenance.
• NP572055.RAov3yzZyqMlcAt7xYT5l1jY9N3DpWwZP11GLChlnexTE130_assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572055.RAov3yzZyqMlcAt7xYT5l1jY9N3DpWwZP11GLChlnexTE130_provenance.
• NP774419.RAeEt3VtppWN0mEGK1Feg-uQWNFjZeGI2xUkEguvGrDWw130_assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP774419.RAeEt3VtppWN0mEGK1Feg-uQWNFjZeGI2xUkEguvGrDWw130_provenance.
• NP670862.RAfoh5QtoIZj23p6b41o3-kjzjynrlFg3ZzwdO3t55oCg130_assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670862.RAfoh5QtoIZj23p6b41o3-kjzjynrlFg3ZzwdO3t55oCg130_provenance.
• assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_provenance.
• NP947951.RATS40yu0QWgHPFkI7HjH8_7bMQxZHAnQYUWwqG3zCzKA130_assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947951.RATS40yu0QWgHPFkI7HjH8_7bMQxZHAnQYUWwqG3zCzKA130_provenance.
• NP947953.RAQDjv-vbeHQuiCeHReq7IDvKrkmgVmZo6UGQLIlxKejw130_assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947953.RAQDjv-vbeHQuiCeHReq7IDvKrkmgVmZo6UGQLIlxKejw130_provenance.
• NP773661.RAmk36frPqTEZg1T2lRo9uXUdJavXoLgmIDU74uuBqVUA130_assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773661.RAmk36frPqTEZg1T2lRo9uXUdJavXoLgmIDU74uuBqVUA130_provenance.
• NP670843.RAm6TuNs-X9_brxE7PxqCyXtaTaMhzSi5lhBEVOMR9t8o130_assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670843.RAm6TuNs-X9_brxE7PxqCyXtaTaMhzSi5lhBEVOMR9t8o130_provenance.
• NP947954.RAq1XFwCawPTeST93CCh7ErrjoD2WDJL3TMQCgEb80Olc130_assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947954.RAq1XFwCawPTeST93CCh7ErrjoD2WDJL3TMQCgEb80Olc130_provenance.
• NP947955.RAm4Xbd40ZXkqhwEwFtLhJAkYZHtE5BbPw85axDg-Eg-Q130_assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947955.RAm4Xbd40ZXkqhwEwFtLhJAkYZHtE5BbPw85axDg-Eg-Q130_provenance.
• NP773648.RAMg7uC2lysPfeMJw_LVSr2JRgl_BWmp0uo6Uw6H4UsC4130_assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773648.RAMg7uC2lysPfeMJw_LVSr2JRgl_BWmp0uo6Uw6H4UsC4130_provenance.
• NP919878.RAOEe2n5M3StSQlX9JZPdflP4cWIzOQD09sYyP08lZ6eU130_assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919878.RAOEe2n5M3StSQlX9JZPdflP4cWIzOQD09sYyP08lZ6eU130_provenance.